Clinical Trial Update: Adverse Events With Magnesium Sulfate

View source ↗

Summary

The ClinicalTrials.gov update indicates that the trial evaluating magnesium sulfate for lung diseases has been withdrawn due to adverse events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Diseases

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases | Status: WITHDRAWN